Pharmacogenomics studies how genetic variations influence an individual’s response to medications, enabling safer, more effective, and personalized drug therapy. By analyzing genes involved in drug absorption, metabolism, distribution, and excretion, researchers identify biomarkers that predict whether a patient will respond well, poorly, or adversely to specific treatments. This field plays a pivotal role in optimizing dosages, reducing side effects, and selecting the most suitable medications for conditions such as cancer, cardiovascular disease, psychiatric disorders, and chronic illnesses. Pharmacogenomic insights help prevent adverse drug reactions one of the leading causes of hospitalizations worldwide and support the development of tailored treatment plans.
| Stage 1 |
Initial Quality & Plagiarism Check The manuscript is reviewed for journal scope, basic submission requirements, ethical compliance, and similarity/plagiarism concerns. |
| Stage 2 |
Editorial Assessment & Peer Review Manuscripts that pass the initial screening undergo editorial assessment and independent peer review in accordance with the journal's peer-review policy. |
| Stage 3 |
Revision & Editorial Decision Authors may be requested to revise their manuscript based on reviewer and editor comments. A final editorial decision is made after the required review and revision stages are completed. |
| Stage 4 |
Production & Publication Accepted manuscripts proceed to production, author proofing, final quality checks, and online publication. |
| English | Publication Language |
| Single-Blind | Peer-Review Model |
| 17% | Acceptance Rate |
| <18% | Similarity Screening Guideline |
| Open Access | Access Model |
All manuscripts undergo editorial assessment and originality screening as part of the journal's evaluation process. The acceptance rate shown is based on journal-level editorial data and may change over time. Similarity reports are assessed editorially and are not interpreted solely on the basis of a numerical similarity score.